|
1
|
Bielack SS, Kempf-Bielack B, Delling G,
Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M,
Winkelmann W, et al: Prognostic factors in high-grade osteosarcoma
of the extremities or trunk: An analysis of 1,702 patients treated
on neoadjuvant cooperative osteosarcoma study group protocols. J
Clin Oncol. 20:776–790. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torres K and Horwitz SB: Mechanisms of
Taxol-induced cell death are concentration dependent. Cancer Res.
58:3620–3626. 1998.PubMed/NCBI
|
|
3
|
Anderson ME: Update on survival in
osteosarcoma. Orthop Clin North Am. 47:283–292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferrari S and Serra M: An update on
chemotherapy for osteosarcoma. Expert Opin Pharmacother.
16:2727–2736. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jaffe N: Osteosarcoma. Review of the past,
impact on the future. The American experience. Cancer Treat Res.
152:239–262. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ferguson JL and Turner SP: Bone cancer:
Diagnosis and treatment principles. Am Fam Physician. 98:205–213.
2018.PubMed/NCBI
|
|
7
|
Liu Q, Xu B and Zhou W: Correlation
between chemotherapy resistance in osteosarcoma patients and PAK5
and Ezrin gene expression. Oncol Lett. 15:879–884. 2018.PubMed/NCBI
|
|
8
|
Steinhardt AA, Gayyed MF, Klein AP, Dong
J, Maitra A, Pan D, Montgomery EA and Anders RA: Expression of
Yes-associated protein in common solid tumors. Hum Pathol.
39:1582–1589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yin J, Dong Q, Zheng M, Xu X, Zou G, Ma G
and Li K: Antitumor activity of dobutamine on human osteosarcoma
cells. Oncol Lett. 11:3676–3680. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shah U, Shah R, Acharya S and Acharya N:
Novel anticancer agents from plant sources. Chin J Nat Med.
11:16–23. 2013. View Article : Google Scholar
|
|
11
|
Khan F, Ahmed F, Pushparaj PN, Abuzenadah
A, Kumosani T, Barbour E, AlQahtani M and Gauthaman K: Ajwa date
(Phoenix dactylifera L.) extract inhibits human breast
adenocarcinoma (MCF7) cells in vitro by inducing apoptosis and cell
cycle arrest. PLoS One. 11:e01589632016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gerber DE: Targeted therapies: A new
generation of cancer treatments. Am Fam Physician. 77:311–319.
2008.PubMed/NCBI
|
|
13
|
Tsauer W, Lin JG, Lin PY, Hsu FL and
Chiang HC: The effects of cantharidin analogues on xanthine oxides.
Anticancer Res. 17:2095–2098. 1997.PubMed/NCBI
|
|
14
|
Lin LH, Huang HS, Lin CC, Lee LW and Lin
PY: Effects of cantharidinimides on human carcinoma cells. Chem
Pharm Bull. 52:855–857. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yeh CB, Su CJ, Hwang JM and Chou MC:
Therapeutic effects of cantharidin analogues without bridging ether
oxygen on human hepatocellular carcinoma cells. Eur J Med Chem.
45:3981–3985. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tao R, Sun WY, Yu DH, Qiu W, Yan WQ, Ding
YH, Wang GY and Li HJ: Sodium cantharidinate induces HepG2 cell
apoptosis through LC3 autophagy pathway. Oncol Rep. 38:1233–1239.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang I, Beus M, Stochaj U, Le PU, Zorc B,
Rajić Z, Petrecca K and Maysinger D: Inhibition of glioblastoma
cell proliferation, invasion, and mechanism of action of a novel
hydroxamic acid hybrid molecule. Cell Death Discov. 5:412018.
View Article : Google Scholar
|
|
18
|
Gamet-Payrastre L, Li P, Lumeau S, Cassar
G, Dupont MA, Chevolleau S, Gasc N, Tulliez J and Tercé F:
Sulforaphane, a naturally occurring isothiocyanate, induces cell
cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer
Res. 60:1426–1433. 2000.PubMed/NCBI
|
|
19
|
Stewart ZA, Westfall MD and Pietenpol JA:
Cell-cycle dysregulation and anticancer therapy. Trends Pharmacol
Sci. 24:139–145. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hindley C and Philpott A: Co-ordination of
cell cycle and differentiation in the developing nervous system.
Biochem J. 444:375–382. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chang L and Karin M: Mammalian MAP kinase
signalling cascades. Nature. 410:37–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo
P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME: Akt
promotes cell survival by phosphorylating and inhibiting a Forkhead
transcription factor. Cell. 96:857–868. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Robertson JD and Orrenius S: Role of
mitochondria in toxic cell death. Toxicology. 181–182. 491–496.
2002.PubMed/NCBI
|
|
24
|
Martinou JC and Youle RJ: Mitochondria in
apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev
Cell. 21:92–101. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Basu-Roy U, Basilico C and Mansukhani A:
Perspectives on cancer stem cells in osteosarcoma. Cancer Lett.
338:158–167. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shangguan WJ, Li H and Zhang YH: Induction
of G2/M phase cell cycle arrest and apoptosis by ginsenoside Rf in
human osteosarcoma MG-63 cells through the mitochondrial pathway.
Oncol Rep. 31:305–313. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu L, Xu Y, Reiter RJ, Pan Y, Chen D, Liu
Y, Pu X, Jiang L and Li Z: Inhibition of ERK1/2 signaling pathway
is involved in melatonin's antiproliferative effect on human MG-63
osteosarcoma cells. Cell Physiol Biochem. 39:2297–2307. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang HW, Tang JY, Ou-Yang F, Wang HR,
Guan PY, Huang CY, Chen CY, Hou MF, Sheu JH and Chang HW: Sinularin
selectively kills breast cancer cells showing G2/M arrest,
apoptosis, and oxidative DNA damage. Molecules. 23:E8492018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Xu W, Yan Z, Zhao W, Mi J, Li J
and Yan H: Metformin induces autophagy and G0/G1 phase cell cycle
arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
J Exp Clin Cancer Res. 37:632018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Saunders EJ, Dadaev T, Leongamornlert DA,
Al Olama AA, Benlloch S, Giles GG, Wiklund F, Gronberg H, Haiman
CA, Schleutker J, et al: Gene and pathway level analyses of
germline DNA-repair gene variants and prostate cancer
susceptibility using the iCOGS-genotyping array. Br J Cancer.
114:945–952. 2016. View Article : Google Scholar : PubMed/NCBI
|
